The Allplex™ 2019-nCoV Assay is an in vitro diagnostic (IVD) real-time reverse transcriptase polymerase chain reaction (RT-PCR) test intended for the qualitative detection of SARS-CoV-2 viral nucleic acids. It is a multiplex, real-time PCR assay for simultaneous detection of 3 target genes of SARS-CoV-2 in a single tube. The assay is designed to detect RdRP and N genes specific for SARS-CoV-2, and E gene for all of Sarbecovirus including SARS-CoV-2.

  • Delivers results faster at a lower cost and more accurately
  • Delivers accurate results for better patient care and peace of mind
  • Automatic Data Analyzer: Easily retrieves results and eliminates interpretation and clerical errors

The Allplex™ 2019-nCoV Assay is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .

Buy the Allplex™ 2019-nCoV Assay for Detecting SARS-CoV-2 for Your WorkPlace

If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the Allplex™ 2019-nCoV Assay for Detecting SARS-CoV-2 for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA)

If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the Allplex™ 2019-nCoV Assay for Detecting SARS-CoV-2 or other rapid tests approved by the TGA.

Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Kindly use the webchat to contact us. This is the most efficient way for us to track and respond to your query. Thank you for your understanding.

Proudly trusted by hundreds of organisations across the Globe

Stay up to date with Rapid Test & Trace Australia

Scroll to Top